Apr 20, 2026
Eli Lilly (LLY) Eyes $2 Billion+ Acquisition of Cancer Therapy Startup Kelonia
Eli Lilly (LLY) stock gained 2.55% amid reports the company is finalizing a $2B+ acquisition of CAR-T cancer biotech Kelonia Therapeutics.
The post Eli Lilly (LLY) Eyes $2 Billion+ Acquisition of Cancer Therapy Startup Kelonia appeared first on Blockonomi.
Source: Blockonomi →Related News
- 6 hours ago
7 Stock Sectors Poised to Dominate the Next Half-Decade: AI, Defense, and Beyond
- 7 hours ago
Nvidia (NVDA) Stock Expands CoreWeave (CRWV) Holdings by 95% in Strategic AI Pla...
- 7 hours ago
Wall Street’s Elite Quietly Accumulated These 5 Stocks in Q1 2026 – Microsoft (M...
- 7 hours ago
Macy’s (M) Stock Surges 6% as Berkshire Hathaway Takes $55M Position
- 7 hours ago
Atlassian (TEAM) Surges 8% on Renewed Enterprise AI Momentum